Keyphrases
Store-operated
100%
Ca2+
100%
Diabetic Nephropathy
100%
Myogenic
100%
Isoform A
92%
Protein Expression
38%
Extracellular Matrix Protein 1 (ECM1)
38%
Diabetes
38%
Reactive Oxygen Species
23%
Mesangial Cells
23%
Drug-gene
15%
New Therapeutic Strategies
15%
High Glucose
15%
RB Pathway
15%
Native Tissue
7%
Mesangial Matrix
7%
Cytosolic Proteins
7%
Delivery Approaches
7%
Early Diabetic Nephropathy
7%
Endogenous Inhibitor
7%
Cell Function
7%
Diabetic Kidney Disease
7%
Expression Level
7%
Clinical Significance
7%
Extracellular Matrix
7%
Fibrosis
7%
Kidney Disease
7%
Therapeutic Intervention
7%
Specific Intent
7%
Diabetic Mice
7%
Smad3
7%
Histology
7%
Kidney Injury
7%
Mesangial Expansion
7%
Glomerulus
7%
Albuminuria
7%
Cell-Associated
7%
Most Common Cause
7%
Gene Delivery System
7%
Glomerular Mesangial Cells
7%
Fibronectin
7%
Pathological Changes
7%
Knockdown
7%
Smad3 Pathway
7%
Overproduction
7%
Gene Delivery
7%
End-stage Renal Disease
7%
Antifibrotic
7%
Putative Drug Targets
7%
Ca2+ Signaling
7%
Glomerular Injury
7%
Medicine and Dentistry
Diabetic Nephropathy
100%
Calcium Channel
100%
Diabetes
45%
Protein Expression
45%
Mesangial Cell
36%
Reactive Oxygen Species
27%
Extracellular Matrix Protein
27%
Scleroprotein
18%
Extracellular Matrix
9%
Cell Function
9%
Clinical Significance
9%
Calcium Signaling
9%
Diabetes Mellitus
9%
In Vitro
9%
Fibrosis
9%
Gene Delivery
9%
Albuminuria
9%
Gene Targeting
9%
Glomerulus
9%
End Stage Renal Disease
9%
Kidney Injury
9%
Kidney Hypertrophy
9%
Fibronectin
9%
Kidney Disorder
9%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Nephropathy
100%
Calcium Channel
100%
Matrix Protein
27%
Reactive Oxygen Metabolite
27%
Scleroprotein
18%
Kidney Injury
9%
Calcium Ion
9%
Kidney Hypertrophy
9%
Albuminuria
9%
Fibrosis
9%
Gene Delivery
9%
End Stage Renal Disease
9%
Diabetes Mellitus
9%
Fibronectin
9%
Kidney Disease
9%
Gene Delivery
9%